TELCON RF PHARMACEUTICAL. Inc.

KOSDAQ 200230.KQ

TELCON RF PHARMACEUTICAL. Inc. Total Non-Current Liabilities for the year ending December 31, 2023: USD 419.66 K

TELCON RF PHARMACEUTICAL. Inc. Total Non-Current Liabilities is USD 419.66 K for the year ending December 31, 2023, a -32.81% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

TELCON RF PHARMACEUTICAL. Inc. Total Non-Current Liabilities for the year ending December 31, 2022 was USD 624.59 K, a -42.99% change year over year.
TELCON RF PHARMACEUTICAL. Inc. Total Non-Current Liabilities for the year ending December 31, 2021 was USD 1.10 M, a -55.06% change year over year.
TELCON RF PHARMACEUTICAL. Inc. Total Non-Current Liabilities for the year ending December 31, 2020 was USD 2.44 M, a 60.81% change year over year.
TELCON RF PHARMACEUTICAL. Inc. Total Non-Current Liabilities for the year ending December 31, 2019 was USD 1.52 M, a 23,129.02% change year over year.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

KOSDAQ: 200230.KQ

TELCON RF PHARMACEUTICAL. Inc.

CEO	Jin-Hun Lim
IPO Date	Nov. 24, 2014
Location	South Korea
Headquarters	54, Gongse-ro
Employees	125
Sector	Communication Services
Industries Satellite Aerospace Automotive Parts Ceramics Composite Materials Defense & Military Hardware & Electronics Telecommunications & Networking

Description

TELCON RF PHARMACEUTICAL. Inc. develops, produces, and sells RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is based in Yongin-si, South Korea.

Key trends

Past 5 years